Global Hematopoietic Stem Cells Transplantation (HSCT) Market Report 2021: Market is Poised to Grow by $1.99 Billion to 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The hematopoietic stem cells transplantation (HSCT) market is poised to grow by $1.99 bn during 2021-2025, progressing at a CAGR of over 6%

This study identifies the increasing investments in the field of regenerative medicines as one of the prime reasons driving the hematopoietic stem cells transplantation (HSCT) market growth during the next few years. The market is driven by the rising number of HSCT and the availability of technologically advanced equipment.

The report on the hematopoietic stem cells transplantation (HSCT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The hematopoietic stem cells transplantation (HSCT) market analysis includes the type segment and geographic landscape.

The publisher’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hematopoietic stem cells transplantation (HSCT) market vendors that include AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and ThermoGenesis Holdings Inc.

Also, the hematopoietic stem cells transplantation (HSCT) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

Key Topics Covered:

Executive Summary

• Market overview

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 – 2025

Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Type

• Market segments
• Comparison by Type
• Autologous HSCT – Market size and forecast 2020-2025
• Allogeneic HSCT – Market size and forecast 2020-2025
• Market opportunity by Type

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2020-2025
• Europe – Market size and forecast 2020-2025
• Asia – Market size and forecast 2020-2025
• ROW – Market size and forecast 2020-2025
• Key leading countries
• Market opportunity By Geographical Landscape
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AllCells Corp.
• bluebird bio Inc.
• FUJIFILM Holdings Corp.
• Lineage Cell Therapeutics Inc.
• Lonza Group Ltd.
• MEDIPOST Co. Ltd.
• Merck and Co. Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• ThermoGenesis Holdings Inc.

For more information about this report visit https://www.researchandmarkets.com/r/21tzrb

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900